Chinese scientists from Shenzhen Bay Laboratory and Peking University found a new approach for cancer treatment, developing an intratumoural vaccine to reprogram tumour cells to act like immune cells, while waking up resident T cells to attack the cancer, according to the findings published in scientific journal Nature yesterday.